
A growing number of chronic liver disease patients, especially those with zzso zzso zzso fatty liver disease or zzso C zzso zzso syndrome, will take statins to prevent cardiovascular zzso As a result, clinicians will weigh complex issues raised by the interaction of statins with liver metabolism in these zzso In this article, we critically review data concerning statins and liver zzso with an emphasis on zzso fatty liver disease and zzso C virus, while also touching on other chronic liver zzso Basic research interests include zzso mechanism of action and their effects on zzso cell signaling pathways and zzso From the clinical standpoint, many chronic liver diseases increase cardiovascular risk and would undeniably benefit from sustained zzso zzso The false alarms and security accompanying zzso monitoring, however, are disturbing in light of the zzso of data on zzso long-term effects on liver zzso Although some actions of statins might eventually prove to be particularly useful in zzso zzso zzso C virus, or zzso zzso others may prove zzso The lack of definitive data makes a fully informed decision zzso Research using zzso zzso is urgently needed to determine the indications and zzso of this extraordinary class of agents in patients with chronic liver zzso 

